Hopp til hovedinnhold
Krokfinger forekommer hyppigere blant folk fra Norden enn fra andre deler av verden.
Krokfinger forekommer hyppigere blant folk fra Norden enn fra andre deler av verden.

Krokfinger, Dupuytrens kontraktur

Dette er en fortykkelse av bindevevshinnen i håndflaten. Over tid kan det føre til at en eller flere fingre blir krokete, og det blir umulig å strekke ut disse fingrene.

Sist oppdatert: Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/muskelskjelett/albue-underarm-hand/dupuytrens-kontraktur/ 

Hva er Dupuytrens kontraktur?

Årsak

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Dupuytrens kontraktur. Referanselisten for dette dokumentet vises nedenfor.

  1. Trojian TH, Chu SM. Dupuytrens disease: diagnosis and treatment. Am Fam Physician 2007; 76: 86-9. PubMed 
  2. Jemec B. Dupuytrens kontraktur. Ugeskr Læger 2003; 165: 1863-5. PubMed 
  3. Townley WA, Baker R, Sheppard N, Grobbelaar O. Dupuytren's contracture unfolded. BMJ 2006; 332: 397-400. PubMed 
  4. Gudmundsson KG, Arngrímsson R, Sigfússon N et al. Epidemiology of Dupuytren's disease. The Reykavik Study. J Clin Epid 2000;53:291-6. PubMed 
  5. Gudmundsson KG, Arngrimsson R, Jonsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scand J Rheumatol 2001; 30: 31-4. PubMed 
  6. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J 2005; 81: 425-8. PubMed 
  7. Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010; 6:715. PubMed 
  8. Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg Br 2003; 28: 351-6. PubMed 
  9. Aggarwal R, Blazar PE. Dupuytren's contracture. UpToDate, last updated Dec 14, 2021. www.uptodate.com 
  10. Liss GM, Stock SR. Can Dupuytren's contracture be work-related?: review of the evidence. Am J Ind Med 1996; 29: 521. PubMed 
  11. Godtfredsen NS, Lucht H, Prescott E, Sorensen TI, Gronbaek M. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol 2004; 57: 858-63. PubMed 
  12. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br 2004; 29: 423-6. PubMed 
  13. Lanting R, van den Heuvel ER, Werker PM. Clusters in Short-term Disease Course in Participants With Primary Dupuytren Disease. J Hand Surg Am. 2016 Mar. 41 (3):354-61.
  14. Trojian TH, Rodner CM. Dupuytren's contracture. BMJ Best Practice, last reviewed 7 Jan 2022. bestpractice.bmj.com 
  15. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am 2007; 32: 767. PubMed 
  16. Gaston RG, MD, Larsen SE, Pess GM, et al. The efficacy and safety of concurrent collagenase Clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am. 2015 Oct;40(10):1963-71 . pmid:26216077 PubMed 
  17. Odinsson A, Brenne LE, Lurie TB, Finsen V. Dupuytren’s contracture. The safety and efficacy of collagenase treatment. J Hand Surg Asian Pac Vol. 2016 Jun;21(2):187-92. . pmid:27454632 PubMed 
  18. Peimer CA, Blazar P, Coleman S, et al. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study): 5-Year Data.. J Hand Surg Am. 2015 Aug;40(8):1597-605 . pmid:26096221 PubMed 
  19. van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717-725. PubMed 
  20. Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am 2005; 30: 1021-5. PubMed 
  21. Brazzelli M, Cruickshank M, Tassie E, et al. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-202. PubMed 
  22. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009; 361: 968-79. New England Journal of Medicine 
  23. Witthaut J, Bushmakin AG, Gerber RA, et al. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study. Clin Drug Investig 2011; 31: 791-8. PubMed 
  24. Gilpin D, Coleman S, Hall S, et al. Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytren's disease. J Hand Surg 2010; 35: 2027-38. PubMed